CTEPH is the result of multiple or recurrent blood clots in the lungs, also known as pulmonary embolism (PE). The clot(s) and resulting scar tissue limit the blood flow to the arteries in the lungs, leading to PH, strain and eventually failure of the right-side of the heart. While all types of PH share some common characteristics, there are certain differences that occur with CTEPH. It is not the same of other forms, such as the more commonly known pulmonary arterial hypertension (PAH).
Adapted from a patient education brochure produced by Patient and Family Education Program.
© University Health Network, Patient and Family Education
Information for patients and families
Click on the headings below to learn:
CTEPH Explained by Specialists
Read Anastasia Bykova's article, "CTEPH: Curable Type of Pulmonary Hypertension," online (article initially published in Connections Magazine, Spring 2016. Vol. 7, No. 1).
PHA Canada thanks Bayer for its support developing this educational website.
Bayer Inc. is required by Health Canada to collect and report any details of adverse events and product technical complaints related to its own products that are raised and/or monitored in relation to or through this website.